Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | DRD2 | P14416 | 9/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | BACE1 | P56817 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13609474 | 0.87 | DRD2 (0.60) | MAPTDRD2LMNAALDH1A1GAA | |
| SCHEMBL22767691 | 0.84 | TDP1 (0.56) | GAASMN1; SMN2 | |
| SCHEMBL12501782 | 0.84 | DRD2 (0.65) | MAPTDRD2LMNAALDH1A1GAA | |
| SCHEMBL8254760 | 0.83 | DRD2 (0.64) | MAPTDRD2LMNAALDH1A1GAA | |
| SCHEMBL18851206 | 0.82 | DRD2 (0.56) | DRD2GAAACHEBACE1SIGMAR1 | |
| SCHEMBL29263630 | 0.82 | DRD2 (0.62) | DRD2GAASIGMAR1 | |
| SCHEMBL31245846 | 0.81 | MAPT (0.67) | MAPTDRD2LMNAALDH1A1GAA | |
| SCHEMBL31246006 | 0.81 | MAPT (0.63) | MAPTDRD2LMNAALDH1A1GAA | |
| SCHEMBL31245936 | 0.80 | MAPT (0.61) | MAPTDRD2LMNAALDH1A1GAA | |
| SCHEMBL4129565 | 0.80 | DRD2 (0.53) | DRD2GAAACHEBACE1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |